VB

Venkata Satyanarayana Murthy Bhamidipati - Profile

Venkata Satyanarayana Murthy Bhamidipati, Director, with 4 companies across 1 industry.

About Venkata Satyanarayana Murthy Bhamidipati

Venkata Satyanarayana Murthy Bhamidipati has 14 years in corporate governance. Holds Director role. Currently with 2 companies, including Sree Lekha Pharma Private Limited and Desika Pharma Private Limited. Formerly with 2 companies, such as Apithecary Pharma Private Limited and Norrish Laboratories Private Limited. Engaged in General Business. Contributes to corporate operations.

Current Companies 2
Past Companies 2
Total Affiliations 4
Oldest Company Age 8
Companies Associated with Venkata Satyanarayana Murthy Bhamidipati
Current Companies
Previous Companies

Explore Director's current and past company associations— Uncover their professional journey today!

Frequently Asked Questions
Who is Venkata Satyanarayana Murthy Bhamidipati?

Venkata Satyanarayana Murthy Bhamidipati has 14 years in corporate governance. Holds Director role. Currently with 2 companies, including Sree Lekha Pharma Private Limited and Desika Pharma Private Limited. Formerly with 2 companies, such as Apithecary Pharma Private Limited and Norrish Laboratories Private Limited. Engaged in General Business. Contributes to corporate operations.

What is Venkata Satyanarayana Murthy Bhamidipati's role in current companies?

Venkata Satyanarayana Murthy Bhamidipati is associated with 2 companies as Director.

What industries does Venkata Satyanarayana Murthy Bhamidipati specialize in?

Venkata Satyanarayana Murthy Bhamidipati has expertise in General Business.

How many years of experience does Venkata Satyanarayana Murthy Bhamidipati have?

Venkata Satyanarayana Murthy Bhamidipati has 14 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available